Single-Use Bioreactors - Global Strategic Business Report: Capitalize on 17.5% CAGR to $18.9B by 2032 as Danaher, Sartorius, Eppendorf and PBS Biotech Accelerate Biomanufacturing

Cut costs and speed time to market with scalable, automated single-use bioreactors that reduce capital outlays, cleaning, turnaround times and contamination risks.

Dublin, Nov. 10, 2026 (GLOBE NEWSWIRE) -- "Single-Use Bioreactors - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.

Global Single-Use Bioreactors Market to Reach US$18.9 Billion by 2032

The global single-use bioreactors market was valued at US$6.1 billion in 2025 and is projected to reach US$18.9 billion by 2032, expanding at a compound annual growth rate (CAGR) of 17.5%. Growth is being supported by rising demand for flexible, scalable and cost-efficient biomanufacturing across biologics, vaccines, biosimilars, monoclonal antibodies, and cell and gene therapies.

Single-Use Bioreactors Transform Biopharmaceutical Manufacturing

Single-use bioreactors are gaining importance in upstream bioprocessing because they reduce cross-contamination risks, cleaning validation requirements, sterilization workloads and facility turnaround times. These operational advantages are accelerating adoption among biopharmaceutical companies managing multi-product portfolios, small production batches, clinical development programs and rapidly changing capacity requirements.

The technology also supports modular manufacturing strategies and can lower initial capital expenditure compared with conventional infrastructure. As biopharmaceutical pipelines expand and manufacturers prioritize speed to market, single-use bioreactor systems are becoming increasingly relevant to clinical and commercial production.

Technology Innovation Strengthens Market Potential

Advances in high-density cell culture, low-shear processing, automation, disposable sensors and process-control platforms are improving the performance and reliability of single-use bioreactors. Integration with perfusion systems, continuous bioprocessing technologies and modular facilities is helping manufacturers increase productivity while maintaining process consistency, data integrity and regulatory compliance.

Research and development investments in advanced controllers, monitoring systems and scalable platforms are expected to create additional opportunities. Demand is also increasing for customizable and integrated bioreactor systems that can support complex biologic molecules and emerging therapeutic modalities.

Market Segments and Regional Outlook

Stirred-tank systems represent a leading product category due to their scalability, versatility and compatibility with established bioprocess workflows. The stirred-tank segment is forecast to reach US$7.8 billion by 2032, advancing at a CAGR of 19.8%. The wave-induced segment is projected to grow at a CAGR of 14.4% over the analysis period.

Major applications include research and development and bioproduction. The market also encompasses mammalian, bacterial, yeast and other cell types, as well as monoclonal antibodies, vaccines, gene-modified cells, stem cells and other molecule categories. Key end users include pharmaceutical and biopharmaceutical companies, contract research organizations, contract development and manufacturing organizations, and academic and research institutes.

North America and Europe remain major single-use bioreactor markets, supported by established biopharmaceutical infrastructure, strong research activity and continued technology investment. The U.S. market was valued at US$1.6 billion in 2025. Asia-Pacific is expected to record significant expansion as biologics capacity and biomanufacturing investment increase. China is forecast to grow at a CAGR of 23.2%, reaching US$4.6 billion by 2032.

Report Scope

The report evaluates the global single-use bioreactors market by value and provides forecasts from 2025 through 2032. Coverage includes:

• Product type: Stirred-tank, wave-induced, bubble-column and other product types
• Cell type: Mammalian, bacterial, yeast and other cell types
• Molecule type: Monoclonal antibodies, vaccines, gene-modified cells, stem cells and other molecules
• Application: Research and development and bioproduction
• End use: Pharmaceutical and biopharmaceutical companies, CROs and CMOs, and academic and research institutes
• Geographies: United States, Canada, Europe, China, Japan, Asia-Pacific, Latin America, the Middle East and Africa

Strategic Market Insights

• Independent annual sales analysis and market forecasts presented in US$ million
• Assessment of growth drivers, market restraints and emerging opportunities
• Regional analysis of established and high-growth biomanufacturing markets
• Competitive intelligence covering major participants and geographic presence
• Actionable insights supporting investment, capacity planning and market-entry decisions
• One year of complimentary updates covering relevant market developments

Companies Featured

• Applikon Biotechnology BV
• Cellexus Ltd.
• Celltainer Biotech B.V.
• Cesco Bioengineering Co. Ltd.
• Danaher Corporation
• Distek, Inc.
• Eppendorf AG
• GE Healthcare
• PBS Biotech, Inc.
• Sartorius AG

Domain Expert Insights

The report incorporates perspectives from industry, enterprise and academic experts to add strategic context beyond conventional secondary research. The report tracks early market signals emerging from company activity, expert discussions, conferences, keynote sessions, panel discussions, corporate disclosures, annual reports and institutional publications.

These validated intelligence sources are synthesized to identify the technologies, investments and competitive developments most likely to influence the global single-use bioreactors market. Company-level analysis examines organizations shaping the competitive environment, while market share assessments are applied at global or regional levels where they provide meaningful insight into geographic differences and industry structure.

Key Attributes:

Report Attribute	Details
No. of Pages	412
Forecast Period	2025 - 2032
Estimated Market Value (USD) in 2025	$6.1 Billion
Forecasted Market Value (USD) by 2032	$18.9 Billion
Compound Annual Growth Rate	17.5%
Regions Covered	Global

For more information about this report visit https://www.researchandmarkets.com/r/c9l7rb

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: 
CONTACT: ResearchAndMarkets.com 
         Laura Wood, Senior  Press Manager 
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470 
         For U.S./ CAN Toll Free Call 1-800-526-8630 
         For GMT Office Hours Call +353-1-416-8900